HM Payson & Co’s Innospec IOSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$40.7K Sell
500
-409
-45% -$32.4K ﹤0.01% 750
2026
Q1
$66.4K Hold
909
﹤0.01% 637
2025
Q4
$69.6K Hold
909
﹤0.01% 631
2025
Q3
$70.1K Hold
909
﹤0.01% 625
2025
Q2
$76.4K Hold
909
﹤0.01% 580
2025
Q1
$86.1K Hold
909
﹤0.01% 546
2024
Q4
$100K Hold
909
﹤0.01% 531
2024
Q3
$103K Hold
909
﹤0.01% 520
2024
Q2
$112K Hold
909
﹤0.01% 486
2024
Q1
$117K Hold
909
﹤0.01% 480
2023
Q4
$112K Hold
909
﹤0.01% 479
2023
Q3
$92.9K Hold
909
﹤0.01% 491
2023
Q2
$91.3K Hold
909
﹤0.01% 494
2023
Q1
$93.3K Hold
909
﹤0.01% 482
2022
Q4
$93.5K Hold
909
﹤0.01% 474
2022
Q3
$78K Hold
909
﹤0.01% 506
2022
Q2
$87K Hold
909
﹤0.01% 489
2022
Q1
$84K Hold
909
﹤0.01% 524
2021
Q4
$82K Hold
909
﹤0.01% 529
2021
Q3
$77K Hold
909
﹤0.01% 526
2021
Q2
$82K Hold
909
﹤0.01% 509
2021
Q1
$93K Hold
909
﹤0.01% 492
2020
Q4
$82K Hold
909
﹤0.01% 504
2020
Q3
$58K Hold
909
﹤0.01% 534
2020
Q2
$70K Hold
909
﹤0.01% 477
2020
Q1
$63K Hold
909
﹤0.01% 465
2019
Q4
$94K Hold
909
﹤0.01% 480
2019
Q3
$81K Hold
909
﹤0.01% 509
2019
Q2
$83K Buy
+909
New +$76.6K ﹤0.01% 513

Other funds holding IOSP

HM Payson & Co's IOSP Position: Q2 2026 in Review

HM Payson & Co reduced its Innospec (IOSP) stake by 45% in Q2 2026, selling an estimated $32.4K and leaving 500 shares worth $40.7K. The position accounts for ﹤0.01% of the portfolio, ranked #750.

HM Payson & Co first reported a position in IOSP in Q2 2019 and has held it in 29 quarters since. The position peaked at $117K in Q1 2024. 282 funds tracked by Wall St. Rank hold IOSP as of Q2 2026.

  • HM Payson & Co held 500 shares of Innospec worth $40.7K as of Q2 2026.
  • HM Payson & Co sold 409 Innospec shares in Q2 2026, an estimated $32.4K.
  • Innospec made up ﹤0.01% of HM Payson & Co's portfolio in Q2 2026, its #750 holding.
  • HM Payson & Co first reported a position in Innospec in Q2 2019 and has held it in 29 quarters since.
  • HM Payson & Co's Innospec position peaked at $117K in Q1 2024.
  • 282 funds tracked by Wall St. Rank held Innospec as of Q2 2026.

Based on HM Payson & Co's 13F filing for Q2 2026, filed 17 Jul 2026.